Antiepileptic drugs available in the U.S.
This resource, developed by the American Epilepsy Society, provides a summary of the drugs available in the U.S. for the treatment of epileptic seizures, including their use, dosage, pharmacokinetics, side effects, contraindications and drug interactions.
The EpiPORT Online Training Program for Clinical Research offers 28 learning modules on key aspects of clinical research in epilepsy. It combines 18 modules created by leaders in epilepsy research with 10 modules from the NIH Introduction to the Principles and Practice of Clinical Research.
EpiPORT Mentorship Program for Clinical Research
Targeted mentorship to investigators looking to hone their skills in clinical research grantsmanship. Available by competitive application, the EPIPORT mentorship program connects investigators with a mentor for guidance on writing and submitting a clinical research grant proposal.
Preclinical Common Data Elements
The TASK3 group of the ILAE/AES Joint Translational Task Force, in collaboration with the NINDS, has created a first set of preclinical common data elements (CDEs) to be used in preclinical epilepsy research studies aiming to develop better treatments for seizures, epilepsies and comorbidities. This project aims to facilitate collaborations across labs, creation of big databases to deposit such data, as well as help comparisons of findings across different studies.
Read CDE reports here:
Special Issue on the TASK3 Preclinical epilepsy CommonData Elements (CDEs) of the ILAE/AES Joint Translational Task Force: Peer review process, acknowledgement to reviewers, and community feedback
Download the full set of companion papers, case report forms and common data element charts from the Epilepsia Open® supplement website that is dedicated to the TASK3 epilepsy preclinical CDEs
Draft reports of this supplement:
CDE Discussion (comments, now closed)
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community